Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The contribution of founder mutations in BRCA1 to breast cancer in Belarus.

Clinical genetics - 1 Oct 2010

Uglanitsa N, Oszurek O, Uglanitsa K, Savonievich E, Lubiński J, Cybulski C, Debniak T, Narod S A, Gronwald J

Abstract excerpt

Mutations in the BRCA1 gene increase susceptibility to both breast and ovarian cancer. In some countries, including several in Eastern Europe, founder mutations in the BRCA1 gene are responsible for a significant proportion of breast cancer cases. To estimate the hereditary proportion of breast cancer in Belarus, we sought the presence of any of three founder mutations in BRCA1 (4153delA, 5382insC and C61G) in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Breast Neoplasms
Share to Founder Effect

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Prevalence

Share to Republic of Belarus

Source

Identifiers

PMID: 20507347
DOI: 10.1111/j.1399-0004.2010.01439.x

Genes

BRCA1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The contribution of founder mutations in BRCA1 to breast cancer in Belarus.PMID 20507347Read ↗

BRCA1 founder mutations compared to ovarian cancer in Belarus.Semantic proximity Read ↗

High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: updateSemantic proximity Read ↗

Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations.Semantic proximity Read ↗

A high proportion of founder BRCA1 mutations in Polish breast cancer families.Semantic proximity Read ↗

Frequency of three BRCA1 gene founder mutations in breast/ovarian cancer families from the Pomerania-Kujawy region of Poland.Semantic proximity Read ↗

The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania.Semantic proximity Read ↗

Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian CancerSemantic proximity Read ↗

Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.Semantic proximity Read ↗

Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.Semantic proximity Read ↗

Breast cancer predisposing alleles in Poland.Semantic proximity Read ↗

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East PolandSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.